José Illnait - Concepedia

Author

José Illnait

Cuban Neuroscience Center

Also Known As

Illnait, José, Jose Illnait, José Illnait, Más, Rosa

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Cuban Neuroscience Center Hospital Oncológico Docente "Conrado Benítez García"Centro Nacional de Investigaciones Científicas

About

José Illnait is an author at Cuban Neuroscience Center specializing in medicine, pharmacology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	724
2	Public Health	2	2	53
3	Allergy	2	2	39
4	Health Sciences	1	1	56
5	Biochemistry	1	1	123

José Illnait

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Hypercholesterolemia in NIDDM With Policosanol Omayda Torres, A J Agramonte, José Illnait, Diabetes Care	1995	124
Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet Roberto Menédez, Lourdes Arruzazabala, R Más, British Journal Of Nutrition NutritionCholesterol BiosynthesisOxysterolBiochemistryLipid Nutrition	1997	123
Effect of policosanol in lowering cholesterol levels in patients with type II hypercholesterolemia Ernesto Aneiros, Rosa Más, Braulio Calderon, Current Therapeutic Research Lipid DisorderOxysterolType Ii HypercholesterolemiaCardiovascular DiseaseMedicine	1995	88
Effects of Policosanol and Lovastatin in Patients with Intermittent Claudication: A Double-Blind Comparative Pilot Study Gladys Castaño, Rosa Más, Lilia Fernández, Angiology	2003	59
One-year efficacy and safety of policosanol in patients with type II hypercholesterolemia P. Gomila Pons, M.R. Millán Rodríguez, Rosa Más, Current Therapeutic Research Lipid DisorderCardiovascular DiseaseType Ii HypercholesterolemiaMedicineOne-year Efficacy	1994	58
Effects of policosanol on hypercholesterolemic patients with abnormal serum biochemical indicators of hepatic function Ramiro Zardoya, Leonel Tula, Gladys Castaño, Current Therapeutic Research Metabolic SyndromeLipid DisorderHepatologyHypercholesterolemic PatientsMedicine	1996	56
One-year study of the efficacy and safety of policosanol (5 mg twice daily) in the treatment of type II hypercholesterolemia Gladys Castaño, Rosa Más, Manuel Nodarse, Current Therapeutic Research Lipid DisorderCardiovascular DiseaseType Ii HypercholesterolemiaMedicineOne-year Study	1995	53
Effects of policosanol on patients with non—insulin-dependent diabetes mellitus and hypercholesterolemia: a pilot study Rafael Alvarez, Rosa Más, José Illnait, Current Therapeutic Research Metabolic SyndromeNon—insulin-dependent Diabetes MellitusDiabetes ManagementCardiovascular DiseaseDiabetes	1997	53
Effects of policosanol in hypertensive patients with type II hypercholesterolemia Gladys Castaño, Leone Tula, Miguel Canetti, Current Therapeutic Research Metabolic SyndromeHypertensionCardiovascular DiseaseType Ii HypercholesterolemiaAntihypertensive Therapy	1996	50
Efficacy and tolerability of policosanol in elderly patients with type II hypercholesterolemia: a 12-month study Gladys Castaño, Miguel Canetti, Marta Moreira, Current Therapeutic Research 12-Month StudyLipid DisorderType Ii HypercholesterolemiaCardiovascular DiseaseElderly Patients	1995	44

Page 1